Form 8-K - Current report:
SEC Accession No. 0001213900-26-075514
Filing Date
2026-07-06
Accepted
2026-07-06 16:30:16
Documents
14
Period of Report
2026-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0297153-8k_longeveron.htm   iXBRL 8-K 67400
2 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF LONGEVERON INC., ea029715301ex3-1.htm EX-3.1 8377
3 PRESS RELEASE DATED JULY 6, 2026 ea029715301ex99-1.htm EX-99.1 15280
4 GRAPHIC ea029715301_ex99-1img1.jpg GRAPHIC 3019
  Complete submission text file 0001213900-26-075514.txt   279819

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20260630.xsd EX-101.SCH 3020
6 XBRL LABEL FILE lgvn-20260630_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE lgvn-20260630_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0297153-8k_longeveron_htm.xml XML 3439
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 261156324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)